NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

Cambrex Corp., a contract manufacturer of small molecules and active pharmaceutical ingredients (APIs) for drug clinical trials, is expanding again in High Point to meet growing business demand for its services.
Grifols, a Spanish biotherapeutics company that employs some 2,500 people in North Carolina, donated more than 25 million international units (IU) of blood clotting factor in 2017, as part of an eight-year commitment to changing the lives of people with hemophilia in 47 countries who have limited access to treatment.
​​​​​​​Good timing had a lot to do with the success of FoodLogiQ, the Durham-based software as a service (SaaS) provider of food traceability, safety and supply chain transparency, says co-founder Andrew Kennedy.
Camras Vision, an NCBiotech portfolio company developing a new medical device for treating glaucoma, has closed on $5.7M in equity funding in a Series A round.
Camras Vision, developer of a new medical device for treating glaucoma, won the Emerging Company Award at SEBIO’s 19th Annual Investor and Partnering Forum in Pinehurst. The honor came a few days before the company expects to close on $5 million in Series A financing.
Biovet S.A. Laboratories, a Spanish animal-nutrition company, has established a small office in Research Triangle Park to better serve the North American market.
Two North Carolina medical technology companies are among the six chosen to pitch their wares next Monday, April 9, during the inaugural Southeast Region Pitch Event at the North Carolina Biotechnology Center.
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy and Fast Track designations to Fennec Pharma’s drug designed to protect the hearing of children undergoing chemotherapy.
Two years after launching its U.S. subsidiary MP Pharma Services in Research Triangle Park, MedPharm has expanded its workforce and invested nearly $1M in new technology at the R&D facility. The U.K.-based company provides performance testing of topical and transdermal drug formulations and other contract services.
“How do we take advantage of this new world of biotechnology” affecting agriculture, asked Ann Bartuska, Ph.D., vice president of Land, Water, and Nature with Resources for the Future at the 2018 AgBiotech Summit. “There are a lot of opportunities in emerging technologies we have yet to capitalize on.”
Enhancing soil health is “One of those rare win-win situations,” Wayne Honeycutt, president and CEO of the Morrisville, NC-based Soil Health Institute told the 2018 Ag Biotech Summit. “It’s good for the farmer and for the environment.”
Many of us chose a career in the life sciences to make a difference. To cure diseases. To improve the environment. To feed the world. But it’s easy to lose the big picture as we focus on the details of our daily routine.

North Carolina is one of five states consistently recognized for its specialized life science industry. The state’s strong network of life science companies, universities and skilled workforce provide a strong advantage for companies of all sizes and stages of development. Statewide, North Carolina has more than 700 life science companies with 63,000 employees, and employment within life sciences is growing at 6.6 percent – triple the national average.

Scientists, executives and farmers at the 2018 Ag Biotech Summit focused on soil health agreed on its importance to plant, animal and human health.

Bioventus, a global orthobiologics company based in Durham, has launched Durolane, its single-injection, hyaluronic acid (HA) joint lubricant for treating knee osteoarthritis pain, following FDA approval last summer.
scroll back to top of page